Big Pharma’s Stealth War on Med Spas (Reviewing AmSpa’s 'Death by Paperwork')
Twelve hours.
That’s roughly how long it takes for a heavily bankrolled pharmaceutical lobby to hijack a state senate bill. I've tuned into hundreds of legal and medical podcasts over the years, and you can usually detect the exact moment a host realizes they just barely survived a legislative firing squad.
On this week's AmSpa Medical Spa Insider drop—fittingly dubbed "Compliance is Cool: Death By Paperwork"—founder Alex Tiersch and General Counsel Patrick O'Brien sound exactly like two guys brushing the dust off their shoulders after a brawl.
And honestly? The story they unpack is kind of terrifying.
The Trojan Horse of Indiana
If you aren't paying attention to Indiana Senate Bill 282, you probably should be. Right now. Because what happened in Indianapolis is already metastasizing into Florida, Iowa, and Arizona.
Here is the messy reality. A bill that started as a seemingly benign check on compounding pharmacies (read: the wildly lucrative GLP-1 weight loss market) suddenly sprouted a mutant second head. Almost overnight, it transformed into an oppressive regulatory nightmare for medical spas.
Why? Well, Eli Lilly happens to be headquartered in Indianapolis. They like their profits. And apparently, they don't mind throwing their considerable weight around to squeeze the compounding market, even if it means inadvertently catching the entire aesthetic industry in the crossfire.
Tiersch doesn't sugarcoat the power dynamic. When he hit the ground in Indiana, he found out the opposition had marshaled roughly six separate lobbying firms. AmSpa? They had to scramble just to secure a single advocate to get a seat at the table.
Golden Nugget: "We're not dealing with, 'oh, let's sit down and have a good civil conversation about policy and make a good strong law.' Like, that's not how it works. You either get on the train or the train runs you over." — Alex Tiersch
Death by a Thousand Drop-Down Menus
Listening to O'Brien meticulously detail the original drafted language is enough to make any clinic owner break out in hives. This wasn't standard oversight. It was designed to paralyze.
Before the AmSpa team managed to negotiate massive, frantic amendments during a marathon 12-hour session, the bill tried to force some truly unhinged requirements:
- The "Contemplation" Clause: Forcing spas to list every single treatment or medication they were even thinking about offering.
- The Employee Roster: Mandating a public registry of every single employee in the building.
- The Reconstitution Trap: Attempting to classify the basic, manufacturer-directed mixing of Botox as actual "compounding"—which would have essentially made basic neurotoxin injections illegal for standard spas overnight.
Wild, right?
Luckily, the legislative committee was actually receptive to logic (a rare twist in politics), and the most catastrophic elements were stripped out. Dr. Barrett, the retiring chair of the public health committee, actually read the room and helped strike the toxic language. But it was a damn close shave.
The New Jersey Rug Pull
As a weirdly stressful cherry on top, they pivot at the very end to New Jersey. If you're an advanced practice nurse (APN) or PA in the Garden State, my sympathies.
The state just abruptly yanked the COVID-era independent practice waivers that have allowed practitioners to work without a collaborating physician for the last five years. No real transition period. Just a sudden, bureaucratic snap of the fingers, throwing hundreds of thriving practices into legal limbo as they scramble to find a supervising doc. It's bureaucratic whiplash at its finest.
I guess the ultimate takeaway from this episode isn't just that compliance is necessary. It's that hoping for the best is a terrible business strategy. The big guys are playing for keeps. And if you aren't watching your own backyard, they will absolutely pave right over it.
Listen to Medical Spa Insider: https://podranker.com/podcast/medical-spa-insider